79 related articles for article (PubMed ID: 20887713)
21. Acute cadmium chloride administration induces hepatic and renal CYP2A5 mRNA, protein and activity in the mouse: involvement of transcription factor NRF2.
Abu-Bakar A; Satarug S; Marks GC; Lang MA; Moore MR
Toxicol Lett; 2004 Mar; 148(3):199-210. PubMed ID: 15041070
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional regulation of human carboxylesterase 1A1 by nuclear factor-erythroid 2 related factor 2 (Nrf2).
Maruichi T; Fukami T; Nakajima M; Yokoi T
Biochem Pharmacol; 2010 Jan; 79(2):288-95. PubMed ID: 19715681
[TBL] [Abstract][Full Text] [Related]
23. Regulation of human carbonyl reductase 1 (CBR1, SDR21C1) gene by transcription factor Nrf2.
Miura T; Taketomi A; Nishinaka T; Terada T
Chem Biol Interact; 2013 Feb; 202(1-3):126-35. PubMed ID: 23247010
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the Cyp2a5 gene involves an aryl hydrocarbon receptor-dependent pathway.
Arpiainen S; Raffalli-Mathieu F; Lang MA; Pelkonen O; Hakkola J
Mol Pharmacol; 2005 Apr; 67(4):1325-33. PubMed ID: 15657367
[TBL] [Abstract][Full Text] [Related]
25. Tumour suppressor protein p53 regulates the stress activated bilirubin oxidase cytochrome P450 2A6.
Hu H; Yu T; Arpiainen S; Lang MA; Hakkola J; Abu-Bakar A
Toxicol Appl Pharmacol; 2015 Nov; 289(1):30-9. PubMed ID: 26343999
[TBL] [Abstract][Full Text] [Related]
26. Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway.
Maher JM; Dieter MZ; Aleksunes LM; Slitt AL; Guo G; Tanaka Y; Scheffer GL; Chan JY; Manautou JE; Chen Y; Dalton TP; Yamamoto M; Klaassen CD
Hepatology; 2007 Nov; 46(5):1597-610. PubMed ID: 17668877
[TBL] [Abstract][Full Text] [Related]
27. Induction of drug-metabolizing enzymes by garlic and allyl sulfide compounds via activation of constitutive androstane receptor and nuclear factor E2-related factor 2.
Fisher CD; Augustine LM; Maher JM; Nelson DM; Slitt AL; Klaassen CD; Lehman-McKeeman LD; Cherrington NJ
Drug Metab Dispos; 2007 Jun; 35(6):995-1000. PubMed ID: 17353348
[TBL] [Abstract][Full Text] [Related]
28. Effects of Fatty Acids on CYP2A5 and Nrf2 Expression in Mouse Primary Hepatocytes.
Cui Y; Wang Q; Yi X; Zhang X
Biochem Genet; 2016 Feb; 54(1):29-40. PubMed ID: 26423681
[TBL] [Abstract][Full Text] [Related]
29. Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors.
Al Koudsi N; Hoffmann EB; Assadzadeh A; Tyndale RF
Eur J Clin Pharmacol; 2010 Mar; 66(3):239-51. PubMed ID: 20012030
[TBL] [Abstract][Full Text] [Related]
30. Multiple androgen response elements cooperate in androgen regulated activity of the type 1 neutral endopeptidase promoter.
Zheng R; Shen R; Goodman OB; Nanus DM
Mol Cell Endocrinol; 2006 Oct; 259(1-2):10-21. PubMed ID: 16949732
[TBL] [Abstract][Full Text] [Related]
31. Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2. Evidence that the coffee-specific diterpenes cafestol and kahweol confer protection against acrolein.
Higgins LG; Cavin C; Itoh K; Yamamoto M; Hayes JD
Toxicol Appl Pharmacol; 2008 Feb; 226(3):328-37. PubMed ID: 18028974
[TBL] [Abstract][Full Text] [Related]
32. Cytochrome P450 2C11 5'-flanking region and promoter: regulation by aromatic hydrocarbons in vitro.
Sawaya RM; Riddick DS
Toxicology; 2008 Jun; 248(2-3):104-12. PubMed ID: 18440119
[TBL] [Abstract][Full Text] [Related]
33. The chalcone compound isosalipurposide (ISPP) exerts a cytoprotective effect against oxidative injury via Nrf2 activation.
Han JY; Cho SS; Yang JH; Kim KM; Jang CH; Park DE; Bang JS; Jung YS; Ki SH
Toxicol Appl Pharmacol; 2015 Aug; 287(1):77-85. PubMed ID: 26028482
[TBL] [Abstract][Full Text] [Related]
34. Modulation of NAD(P)H:quinone oxidoreductase by vanadium in human hepatoma HepG2 cells.
Abdelhamid G; Anwar-Mohamed A; Elmazar MM; El-Kadi AO
Toxicol In Vitro; 2010 Sep; 24(6):1554-61. PubMed ID: 20599494
[TBL] [Abstract][Full Text] [Related]
35. Involvement of pregnane X receptor in the regulation of CYP2B6 gene expression by oltipraz in human hepatocytes.
Piton A; Rauch C; Langouet S; Guillouzo A; Morel F
Toxicol In Vitro; 2010 Mar; 24(2):452-9. PubMed ID: 19833192
[TBL] [Abstract][Full Text] [Related]
36. Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene.
Vollrath V; Wielandt AM; Iruretagoyena M; Chianale J
Biochem J; 2006 May; 395(3):599-609. PubMed ID: 16426233
[TBL] [Abstract][Full Text] [Related]
37. Reduction in antioxidant defenses may contribute to ochratoxin A toxicity and carcinogenicity.
Cavin C; Delatour T; Marin-Kuan M; Holzhäuser D; Higgins L; Bezençon C; Guignard G; Junod S; Richoz-Payot J; Gremaud E; Hayes JD; Nestler S; Mantle P; Schilter B
Toxicol Sci; 2007 Mar; 96(1):30-9. PubMed ID: 17110534
[TBL] [Abstract][Full Text] [Related]
38. Generation and characterization of a transgenic mouse model with hepatic expression of human CYP2A6.
Zhang QY; Gu J; Su T; Cui H; Zhang X; D'Agostino J; Zhuo X; Yang W; Swiatek PJ; Ding X
Biochem Biophys Res Commun; 2005 Dec; 338(1):318-24. PubMed ID: 16126166
[TBL] [Abstract][Full Text] [Related]
39. Regulation of transforming growth factor β1-dependent aldose reductase expression by the Nrf2 signal pathway in human mesangial cells.
Wang F; Tian F; Whitman SA; Zhang DD; Nishinaka T; Zhang N; Jiang T
Eur J Cell Biol; 2012 Oct; 91(10):774-81. PubMed ID: 22951256
[TBL] [Abstract][Full Text] [Related]
40. Aryl hydrocarbon receptor nuclear translocator and upstream stimulatory factor regulate Cytochrome P450 2a5 transcription through a common E-box site.
Arpiainen S; Lämsä V; Pelkonen O; Yim SH; Gonzalez FJ; Hakkola J
J Mol Biol; 2007 Jun; 369(3):640-52. PubMed ID: 17466327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
